Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

LexinFintech to release Q1 2026 unaudited results on May 25 with a conference call.

Company Fundamentals
19 May 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

LexinFintech Holdings Ltd., a leading personal financial service provider in China, announced it will report its unaudited financial results for Q1 2026 on May 25 before the U.S. market opens. The company will hold a conference call for investors and analysts on the same day to discuss the results. This update is important as it provides insights into LexinFintech's recent financial performance and business outlook. Investors can register online to join the call or access a live webcast through the company's investor relations website.

More News

Hedge funds boost semiconductor bets as SOXX ETF exposure hits record highs in Q1 2026

Hedge funds boost semiconductor bets as SOXX ETF exposure hits record highs in Q1 2026

In the first quarter of 2026, hedge funds dramatically increased their investments in semiconductor stocks, pushing sector exposure to a record 19% of global hedge fund portfolios, more than doubling since the start of the year. Major investors like ...

Market News
Bullish
35 minutes ago
Oriental Rise Holdings shares jump nearly 19% after board approves 1-for-4 reverse stock split

Oriental Rise Holdings shares jump nearly 19% after board approves 1-for-4 reverse stock split

Oriental Rise Holdings Ltd. saw its stock price surge 18.84% after hours following a board-approved reverse stock split at a 1-for-4 ratio. The reverse split, approved by shareholders, reduces the number of outstanding shares and increases the per-sh...

Company Fundamentals
Bullish
49 minutes ago
Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix.

Onconetix shares jump 23.65% after clinical study boosts confidence in prostate cancer test Proclarix.

Onconetix Inc. stock surged 23.65% in after-hours trading following positive clinical validation of its prostate cancer blood test, Proclarix. Two new peer-reviewed studies from Denmark showed Proclarix can reduce unnecessary biopsies and overdiagnos...

Market News
Bullish
1 hour ago
U-BX Technology shares drop 15.6% after announcing a 1-for-25 reverse stock split.

U-BX Technology shares drop 15.6% after announcing a 1-for-25 reverse stock split.

U-BX Technology's stock fell 15.6% in after-hours trading following the announcement of a 1-for-25 reverse stock split effective Friday. The move will reduce the number of outstanding shares significantly to maintain Nasdaq listing compliance. The co...

Company Fundamentals
Bearish
2 hours ago
Anaveon appoints Eric Zanelli as CSO and Jill Jene as CBO to boost clinical and business growth.

Anaveon appoints Eric Zanelli as CSO and Jill Jene as CBO to boost clinical and business growth.

Anaveon, a Swiss biotech firm focused on precision biologics for autoimmune diseases, announced the appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer. These new executives bring extensive expertise in im...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App